Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × MEK inhibitor I × Tumor-Agnostic × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1 Other solid neoplasm 1

Conditions

Interventions

Radiotherapy 9 Cisplatin 9 Gemcitabine 7 Drug Therapy 7 Blood Specimen Collection 7 Fluorouracil 6 Docetaxel 6 Carboplatin 6 Capecitabine 6 Pemetrexed 5 Nivolumab 5 Trastuzumab 4 Positron Emission Tomography Computed Tomography 4 Paclitaxel 4 Oxaliplatin 4 Everolimus 4 Cetuximab 4 Biopsy 4 pembrolizumab 3 indibulin 3 icotinib 3 Surveys and Questionnaires 3 Standard of Care 3 Radiosurgery 3 Neoadjuvant Therapy 3 Magnetic Resonance Spectroscopy 3 Interleukin-2 3 Immune Checkpoint Inhibitors 3 Granulocyte-Macrophage Colony-Stimulating Factor 3 Gallium-68 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05080361 2021-10-15

BRAFREC

University Hospital, Caen

16,000 enrolled

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡